Skip to main content
. 2017 Sep 12;8(51):88719–88729. doi: 10.18632/oncotarget.20838

Figure 2. Stattic inhibited STAT3 activation in ESCC cells.

Figure 2

(A) TE13, EC9706 and EC1 cells were treated with indicated concentrations of Stattic. The expression of STAT3, p-STAT3, iNOS, Cox2, and Pentraxin-3 were examined by immunoblotting with specific antibodies. The level of β-actin was used as a control. (B) EC9706, TE13 and EC1 cells were exposed to 30 ng/ml of IL-6 in the presence of indicated concentrations of Stattic. The levels of STAT3 and pSTAT3 were examined by immunoblotting.